Biodesix (BDSX) Competitors $7.15 +0.02 (+0.28%) Closing price 04:00 PM EasternExtended Trading$7.21 +0.06 (+0.84%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BDSX vs. XGN, DCGO, CORBF, QIPT, SERA, BNR, ATPC, PIII, EUDA, and BMGLShould you be buying Biodesix stock or one of its competitors? The main competitors of Biodesix include Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), Quipt Home Medical (QIPT), Sera Prognostics (SERA), Burning Rock Biotech (BNR), Agape ATP (ATPC), P3 Health Partners (PIII), EUDA Health (EUDA), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry. Biodesix vs. Its Competitors Exagen DocGo Global Cord Blood Quipt Home Medical Sera Prognostics Burning Rock Biotech Agape ATP P3 Health Partners EUDA Health Basel Medical Group Biodesix (NASDAQ:BDSX) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Which has more risk and volatility, BDSX or XGN? Biodesix has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Exagen has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Do analysts prefer BDSX or XGN? Biodesix currently has a consensus price target of $32.50, suggesting a potential upside of 354.55%. Exagen has a consensus price target of $12.00, suggesting a potential upside of 21.83%. Given Biodesix's higher probable upside, research analysts plainly believe Biodesix is more favorable than Exagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodesix 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Exagen 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, BDSX or XGN? Exagen has lower revenue, but higher earnings than Biodesix. Exagen is trading at a lower price-to-earnings ratio than Biodesix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodesix$76.56M0.68-$42.93M-$5.80-1.23Exagen$55.64M3.89-$15.11M-$0.89-11.07 Do institutionals and insiders hold more shares of BDSX or XGN? 21.0% of Biodesix shares are owned by institutional investors. Comparatively, 75.3% of Exagen shares are owned by institutional investors. 30.1% of Biodesix shares are owned by company insiders. Comparatively, 12.6% of Exagen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor BDSX or XGN? In the previous week, Biodesix had 6 more articles in the media than Exagen. MarketBeat recorded 7 mentions for Biodesix and 1 mentions for Exagen. Exagen's average media sentiment score of 1.57 beat Biodesix's score of 1.09 indicating that Exagen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Exagen 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is BDSX or XGN more profitable? Exagen has a net margin of -28.85% compared to Biodesix's net margin of -53.66%. Exagen's return on equity of -130.38% beat Biodesix's return on equity.Company Net Margins Return on Equity Return on Assets Biodesix-53.66% -269.67% -43.94% Exagen -28.85%-130.38%-34.69% SummaryExagen beats Biodesix on 11 of the 16 factors compared between the two stocks. Get Biodesix News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BDSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDSX vs. The Competition Export to ExcelMetricBiodesixMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.42M$7.87B$5.79B$10.49BDividend YieldN/A2.78%5.61%4.57%P/E Ratio-1.23164.55348.8926.87Price / Sales0.6873.08522.55164.30Price / CashN/A25.3826.0131.15Price / Book2.4947.9515.536.50Net Income-$42.93M$241.92M$3.29B$271.42M7 Day Performance-5.92%66.93%200.87%3.69%1 Month Performance-21.15%47.93%184.38%8.07%1 Year Performance-80.14%42.10%325.51%29.65% Biodesix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDSXBiodesix3.6874 of 5 stars$7.15+0.3%$32.50+354.5%-80.2%$52.42M$76.56M-1.23220Positive NewsAnalyst ForecastXGNExagen4.46 of 5 stars$9.31-4.4%$12.00+28.9%+223.0%$214.32M$55.64M-10.46220Positive NewsDCGODocGo2.1278 of 5 stars$1.56+2.0%$3.59+130.1%-58.3%$149.65M$616.55M-8.214,407News CoveragePositive NewsCORBFGlobal Cord BloodN/A$1.00+11.1%N/A-63.3%$121.55M$196.12M0.001,200Gap UpQIPTQuipt Home Medical1.959 of 5 stars$2.66-1.1%$3.15+18.4%+0.4%$116.86M$245.91M-11.081,200Positive NewsSERASera Prognostics1.3096 of 5 stars$3.10flatN/A-55.4%$116.79M$80K-3.65120Gap UpBNRBurning Rock Biotech0.606 of 5 stars$8.71+4.9%N/A+165.2%$89.32M$70.67M-4.581,390News CoverageATPCAgape ATP0.1896 of 5 stars$1.28-3.0%N/A-32.8%$66.01M$1.32M-3.1240PIIIP3 Health Partners2.7129 of 5 stars$8.72+1.3%$16.25+86.5%-61.7%$61.81M$1.50B-0.19500EUDAEUDA Health0.4081 of 5 stars$1.06-7.0%N/A-68.3%$42.36M$4.01M0.002Gap UpHigh Trading VolumeBMGLBasel Medical GroupN/A$1.98flatN/AN/A$36.54MN/A0.0036Positive News Related Companies and Tools Related Companies XGN Competitors DCGO Competitors CORBF Competitors QIPT Competitors SERA Competitors BNR Competitors ATPC Competitors PIII Competitors EUDA Competitors BMGL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDSX) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodesix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodesix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
